Accuvest Global Advisors grew its stake in Crocs, Inc. (NASDAQ:CROX – Get Rating) by 45.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,718 shares of the textile maker’s stock after purchasing an additional 1,464 shares during the quarter. Accuvest Global Advisors’ holdings in Crocs were worth $512,000 as of its most recent filing with the SEC.
Other institutional investors have also modified their holdings of the company. Ellevest Inc. raised its stake in shares of Crocs by 6,750.0% in the 3rd quarter. Ellevest Inc. now owns 411 shares of the textile maker’s stock valued at $28,000 after purchasing an additional 405 shares in the last quarter. Wipfli Financial Advisors LLC acquired a new stake in shares of Crocs in the 3rd quarter valued at about $56,000. Quadrant Capital Group LLC raised its stake in shares of Crocs by 269.0% in the 3rd quarter. Quadrant Capital Group LLC now owns 915 shares of the textile maker’s stock valued at $63,000 after purchasing an additional 667 shares in the last quarter. Public Employees Retirement System of Ohio raised its stake in shares of Crocs by 18.6% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 1,227 shares of the textile maker’s stock valued at $84,000 after purchasing an additional 192 shares in the last quarter. Finally, Lazard Asset Management LLC raised its stake in shares of Crocs by 56.6% in the 2nd quarter. Lazard Asset Management LLC now owns 1,821 shares of the textile maker’s stock valued at $88,000 after purchasing an additional 658 shares in the last quarter. Institutional investors and hedge funds own 84.95% of the company’s stock.
Analyst Ratings Changes
Several research firms recently weighed in on CROX. UBS Group increased their price objective on shares of Crocs from $107.00 to $124.00 and gave the stock a “neutral” rating in a research note on Thursday, January 12th. TheStreet upgraded shares of Crocs from a “c+” rating to a “b” rating in a research note on Monday, January 30th. Piper Sandler increased their price objective on shares of Crocs from $118.00 to $145.00 and gave the stock an “overweight” rating in a research note on Thursday, January 12th. Loop Capital increased their price objective on shares of Crocs from $165.00 to $185.00 in a research note on Friday, February 17th. Finally, StockNews.com began coverage on shares of Crocs in a research note on Thursday, March 16th. They set a “hold” rating on the stock. Five investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Crocs has an average rating of “Moderate Buy” and a consensus price target of $138.29.
Insider Activity
In other news, President Michelle Poole sold 11,055 shares of the stock in a transaction that occurred on Friday, February 17th. The shares were sold at an average price of $130.61, for a total value of $1,443,893.55. Following the completion of the transaction, the president now directly owns 134,102 shares in the company, valued at $17,515,062.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CEO Andrew Rees sold 20,000 shares of the firm’s stock in a transaction that occurred on Friday, February 17th. The shares were sold at an average price of $130.77, for a total transaction of $2,615,400.00. Following the completion of the sale, the chief executive officer now directly owns 119,748 shares in the company, valued at $15,659,445.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, President Michelle Poole sold 11,055 shares of the firm’s stock in a transaction that occurred on Friday, February 17th. The stock was sold at an average price of $130.61, for a total transaction of $1,443,893.55. Following the sale, the president now owns 134,102 shares of the company’s stock, valued at $17,515,062.22. The disclosure for this sale can be found here. Insiders sold 66,571 shares of company stock worth $8,354,696 over the last three months. Corporate insiders own 2.71% of the company’s stock.
Crocs Price Performance
NASDAQ CROX opened at $118.59 on Tuesday. Crocs, Inc. has a 52 week low of $46.08 and a 52 week high of $143.50. The company has a current ratio of 1.60, a quick ratio of 0.86 and a debt-to-equity ratio of 2.81. The stock has a market cap of $7.32 billion, a price-to-earnings ratio of 13.65, a price-to-earnings-growth ratio of 0.71 and a beta of 1.89. The company has a 50-day moving average price of $122.30 and a two-hundred day moving average price of $99.27.
Crocs (NASDAQ:CROX – Get Rating) last posted its quarterly earnings data on Thursday, February 16th. The textile maker reported $2.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.18 by $0.47. The business had revenue of $945.16 million during the quarter, compared to analysts’ expectations of $939.16 million. Crocs had a net margin of 15.19% and a return on equity of 118.32%. The business’s revenue was up 61.1% on a year-over-year basis. During the same period last year, the firm posted $2.15 earnings per share. Analysts forecast that Crocs, Inc. will post 11.19 EPS for the current year.
Crocs Company Profile
Crocs, Inc engages in the design, development, manufacturing, worldwide marketing, sale, and distribution of casual footwear and accessories for men, women, and children. It operates through the following segments: North America, Asia Pacific, Europe, Middle East, Africa, and Latin America (EMEALA), and HEYDUDE Brand.